UK SACT Board annual conference – 28 November 2023

DON’T FORGET TO REGISTER!

UK SACT Board annual conference – 28 November 2023

The UK SACT Board* will be hosting its Annual Conference at the Pullman London St Pancras Hotel on Tuesday 28 November 2023. Chaired by Dr Tom Roques, Chair of the UKSB and Vice President, Clinical Oncology at The Royal College of Radiologists, this year’s event will include sessions on SACT capacity in the UK, innovation in SACT practice, a forward look to the next decade in cancer care and digital supportive care.

 

Registration is just £25.00 including VAT. CLICK HERE TO REGISTER

For more information, please visit the UKSB website. 

 

We look forward to seeing you at what will surely be an exciting, educational and informative day.

 

* The UK SACT Board (UKSB) provides guidance, oversight and support for the continuing development of SACT services in the UK.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article